Amine Bourbia MD

Recommended Articles

• Is Bronchitis a Contagious Disease?

  The human respiratory tract starts at the nose and mouth and continues down to the lungs. The air that we breathe in through our nose and mouth passes down the trachea and into the lungs through a series of branched tubes called the bronchi. For a healthy breathing to happen effectively, these tubes...

• Pneumonia: The Signs and Symptoms

  You may be a patient concerned about the symptoms of pneumonia or you may have a friend or relative with symptoms suggestive of pneumonia. There are no universal symptoms that apply to every individual. The symptoms will vary from person to person and depend on the specific situation of each and...

• Antibiotics May Not Alleviate the Symptoms of Sinusitis

  A recent study has shown that antibiotics like amoxicillin are not very effective in controlling the symptoms of sinusitis, which is the infection of sinuses and the nasal passages. The study was conducted on 166 participants and the results are published in the journal of the American Medical...

• Are There any Risk Factors for Bronchitis?

  Bronchitis is a condition which occurs due to the inflammation of bronchial tubes. There are two types of bronchitis; acute bronchitis and chronic bronchitis.There are various factors involved in the development of bronchitis. The lifestyle of a person and his or her medical history are the main...

• What is Acute Bronchitis?

  What is Bronchitis?We often run under weather catching a flu or a cold that stays on for a couple of days to weeks, after which we normally get back to normal. However, sometimes even a small infection of cold or flu, could turn into a bronchitis infection causing much disturbance to your normal...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...